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Abstract 
Patients with influenza infection most commonly present with upper and occasionally lower 
respiratory tract symptoms. However, extrapulmonary presentations such as hepatitis are infrequently 
observed. We report a case of a hemodialysis patient with influenza A infection who presented with 
severe hepatitis and liver failure, while his respiratory symptoms were mild. It is important to 
recognize influenza infection as an unexplained cause of hepatitis and liver failure. In our case, liver 
failure resolved with supportive treatment.  
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Introduction 
Hemodialysis patients are prone to infections due to impaired immunity (1). Influenza infection is one 
of the common respiratory infections in hemodialysis patients and has a higher mortality than the 
general population (2). Respiratory symptoms, fever and malaise are the common clinical features but 
extrapulmonary manifestations may be present or occasionally become the predominant clinical 
presentations.  
  
Case History 
Our patient was a 67 year-old man with end-stage renal failure due to diabetic nephropathy. He 
received peritoneal dialysis for 6 years and was switched to hemodialysis in 2010 after an episode of 
fungal peritonitis. He also had history of ischemic heart disease with coronary artery bypass performed 
in 2010 and an implantable cardioverter defibrillator inserted for inducible ventricular tachycardia in 
2013. He presented with mild productive cough, malaise and fever for 2 days. His blood pressure was 
110/60 mmHg. His oxygen saturation was 97% in room air. He had a low grade fever of 37.8°C. 
Complete blood picture revealed mild lymphopenia (0.79 x10^9/L) and thrombocytopenia 
(95x10^9/L). Liver enzymes were markedly raised with hyperbilirubinemia and clotting profile 
showed prolonged prothrombin time and activated partial thromboplastin time (Table 1). His chest 
X-ray was clear. Nasopharyngeal aspirate was positive for influenza A by rapid viral antigen detection, 
with subsequent RNA sequencing confirming it to be the H3N2 subtype. Blood culture was negative. 
Serological markers for hepatitis A, B, C and E were negative. There was no evidence of systemic 
hypotension. He denied the use of herbal or any over-the-counter medications. Serum paracetamol 
level was undetectable. Computed tomography scan of the abdomen was unremarkable. He was given 
an empirical course of piperacillin/ tazobactam 2.25gm every 8 hours. Oseltamivir was not prescribed 
as his onset of symptoms was over 48 hours when the laboratory diagnosis of influenza A was made. 
He was monitored closely and received hemodialysis in the intensive care unit. His serum ammonia 
level was raised but he did not have any encephalopathy features clinically, nor did he have any other 
symptoms from complications of liver failure. His respiratory symptoms gradually improved. Liver 
function began to improve after day 5. He was discharged from hospital on day 16. His liver function 
and clotting profile gradually normalized after 4 weeks.  
 
Discussion 
This is, to the best of our knowledge, the first and the most severe case of seasonal influenza A H3N2 
infection leading to hepatic failure in a hemodialysis patient without concomitant severe respiratory 
involvement. He made an uneventful recovery after 4 weeks. Influenza A infection is the most likely 
cause of hepatic failure as the patient had no hypotensive episodes, cardiac event, infective hepatitis or 
any exposure to hepatotoxic agents. Liver biopsy has not been performed as the patient had severe 
coagulopathy. 
 
Influenza A is an Orthomyxoviridae. It is a negative –sense, single-stranded enveloped ribonucleic acid 
virus. The most common circulating strain of the winter influenza season of 2014-2015 in the Northern 
Hemisphere was the H3N2 strain (3) .  
 
Influenza A virus not only attacks the respiratory tract but also leads to systemic involvement, either by 
direct viral infection or by triggering a systemic inflammatory response (4). These mechanisms were 
proposed through demonstration of influenza A virus infection in mouse models. Influenza A virus 
could spread to non-respiratory organs. Viral cultivation was shown in the thymus and heart muscle, 
and their RNA was detected in the liver and spleen, possibly spread by transient viremia (5). 
Sanchez-Lanier et al. have found areas of microvesicular fatty metamorphosis and focal hepatic 
necrosis alongside influenza A particles in their mouse experiments (6). However, Polakos et al. 
suggested a different mechanism of influenza A induced liver injury by collateral damage. In their 
mouse model, influenza A virus was absent in the liver but a significant proportion of 
influenza-specific CD8+ T cell was found. Together with activated Kupffer cells, they form an 
inflammatory focus, resulting in apoptosis of the T cells and hepatocytes (7). Reduction of anti-oxidant 
production (e.g. glutathione, Vitamin E) induced by influenza viral infection could also increase the 
risk of hepatic oxidative stress and hepatic damage (8).  
 
Hepatitis or liver failure caused by influenza A virus have been recognized in patients with underlying 
cirrhosis (9), children (10), pregnant women (11) and immunocompromised individuals such as renal 
and liver transplant recipients (12, 13). The degree of hepatic damage is proposed to be determined by 
the magnitude of CD8+T cell immune response and the interaction with pre-existing antibodies to 
influenza. Inadequate antibodies to counteract the influenza infection may trigger CD8+ T cell 
response.Pre-existing influenza antibodies could trigger cross reactive CD8+ T cells memory, 
producing profound CD8+ T cell response and severe liver damage (7). In general, both T and B cell 
immune response are impaired in dialysis patients (14). Nonetheless, preferential T cell activation 
towards Th1 than Th2 cells occurs in hemodialysis patients. Through INFα, Th1 cells provide help to 
CD8+ cytotoxic T cells. The individual variability of T cell immune response remains to be elucidated. 
The bias towards Th1 activity in dialysis patients also explains their poor antibody response after 
influenza vaccination (15), which in turn make them prone to influenza infection. Previous reports 
have demonstrated that a timely prescription of oseltamivir may lead to a faster recovery of liver 
function and reduce morbidity and improve survival (16, 17).In our case, oseltamivir was not 
prescribed due to the delay in presentation from symptom onset. Liver failure improved gradually with 
supportive treatment alone.  
 
Conclusion 
Influenza A infection could predominantly present as severe hepatitis and lead to liver failure in 
hemodialysis patients. Recognition of this extra-pulmonary presentation of influenza A is important as 
this may come alongside with mild or unrecognizable respiratory symptoms. Liver failure resolved 
with supportive treatment.  
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 Table 1. Laboratory parameters of our patient since admission.  
 
Abbreviations: ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; 
NH3, ammonia; APTT, activated partial thromboplastin time; PT, prothrombin time. 
 
 
 
 Reference 
range 
Day 1 Day 2 Day 3 Day 5 Day 7 Day 15 Day 29 
Albumin (g/L) 39-50 37 40 35 32 31 33 36 
Total Bilirubin (umol/L) 4-23 13 55 79 103 87 64 25 
ALP (U/L) 42-110 168 261 261 212 143 274 190 
ALT (U/L) 8-58 1631 >3000 >3000 2314 913 161 43 
AST (U/L) 15-38 2497 >3000 >3000 1760 339 85 51 
NH3 (umol/L) <33 9 - 44 38 - - - 
APTT (seconds) 25.9-33.7 69.4 65.7 84.2 97.0 67.8 44.1 - 
PT (seconds) 11.3-13.5 22.6 78.0 74.3 34.7 19.6 13.5 - 
